Japan Peptide Therapeutics Market Report by Type, Types of Manufacturer, Synthesis Technology, Routes of Administration, Application, and Region 2025-2033
일본의 펩타이드 치료제 시장 규모는 2024년 25억 9,270만 달러로 추정됩니다. 향후 IMARC 그룹은 2033년까지 시장 규모가 47억 7,620만 달러에 달하고, 2025년부터 2033년까지 6.37%의 연평균 성장률(CAGR)을 나타낼 것으로 예측했습니다. 당뇨병을 치료하기 위한 빠르고 정확한 치료법에 대한 수요 증가와 피부 노화의 영향을 완화하기 위해 미용 성형에 대한 개인의 선호도가 높아지면서 시장 성장을 주도하고 있습니다.
본 보고서에서 다룬 주요 질문
- 일본의 펩타이드 치료제 시장은 지금까지 어떻게 성장해 왔고, 앞으로 어떻게 성장할 것인가?
- 코로나19가 일본 펩타이드 치료제 시장에 미치는 영향은?
- 일본 펩타이드 치료제 시장 유형별 분석은?
- 일본 펩타이드 치료제 시장의 제조업체 유형별 분류는?
- 일본 펩타이드 치료제 시장, 합성 기술별 시장 현황은?
- 일본 펩타이드 치료제 시장의 투여 경로별 현황은?
- 일본 펩타이드 치료제 시장 용도별 분석은?
- 일본 펩타이드 치료제 시장의 밸류체인에는 어떤 단계가 있는가?
- 일본 펩타이드 치료제의 주요 촉진요인과 과제는?
- 일본의 펩타이드 치료제 시장 구조와 주요 기업은?
- 일본 펩타이드 치료제 시장에서의 경쟁은 어느 정도인가?
목차
제1장 서문
제2장 조사 범위와 조사 방법
- 조사 목적
- 이해관계자
- 데이터 소스
- 시장 추정
- 조사 방법
제3장 주요 요약
제4장 일본의 펩타이드 치료제 시장 - 서론
제5장 일본의 펩타이드 치료제 시장 구도
- 과거 및 현재 시장 동향(2019-2024년)
- 시장 예측(2025-2033년)
제6장 일본의 펩타이드 치료제 시장 : 유형별 분석
제7장 일본의 펩타이드 치료제 시장 : 제조업체 유형별 분석
제8장 일본의 펩타이드 치료제 시장 : 합성 기술별 분석
- 고상 펩티드 합성
- 액상 펩티드 합성
- 하이브리드 기술
제9장 일본의 펩타이드 치료제 시장 : 투여 경로별 분석
제10장 일본의 펩타이드 치료제 시장 : 용도별 분석
제11장 일본의 펩타이드 치료제 시장 : 경쟁 구도
- 개요
- 시장 구조
- 시장 기업 포지셔닝
- 주요 성공 전략
- 경쟁 대시보드
- 기업 평가 상한
제12장 주요 기업 개요
제13장 일본의 펩타이드 치료제 시장 - 업계 분석
- 성장 촉진요인 및 억제요인과 기회
- Porter의 Five Forces 분석
- 밸류체인 분석
제14장 부록
LSH
Japan peptide therapeutics market size reached USD 2,592.7 Million in 2024. Looking forward, IMARC Group expects the market to reach USD 4,776.2 Million by 2033, exhibiting a growth rate (CAGR) of 6.37% during 2025-2033. The inflating need for fast and precise treatment methods to cure diabetes, along with the increasing inclination among individuals towards cosmetic procedures to mitigate the effects of skin aging, is primarily driving the market growth.
Peptides are highly effective and specific signaling molecules that attach to particular cell surface receptors, including ion channels and G protein-coupled receptors (GPCRs), initiating intracellular responses. In the pharmaceutical sector, they are utilized to develop innovative regenerative therapies capable of targeting various types of cells and influencing their reactions. These therapies, in comparison to other treatment alternatives, are less toxic, generally safe, and well-tolerated. Consequently, they are becoming increasingly popular in clinical applications throughout Japan for the treatment of conditions such as cancer, injuries, infectious diseases, metabolic disorders, and aesthetic concerns.
Japan Peptide Therapeutics Market Trends:
The increasing prevalence of both acute and chronic illnesses, alongside improved access to medical services, stands as a prominent factor that is positively impacting the demand for peptides in the development of innovative therapies, which is primarily driving the market growth. Additionally, peptides are employed in cosmeceutical procedures to mitigate the effects of skin aging. This, combined with the growing awareness among individuals about their physical appearance and the desire to maintain youthful and healthy skin, is propelling the adoption of cosmetic treatments and peptide-based therapeutics worldwide. Furthermore, the introduction of new synthetic techniques that reduce the frequency of injections and enhance the stability and other physical attributes of peptide therapeutics has led to their widespread use in injections for diabetic patients. This, in conjunction with the increasing incidence of diabetes and a preference for rapid and precise treatment methods , is driving the utilization of peptide therapeutics over oral medications. Moreover, the emerging trend of personalized and targeted therapies is driving the demand for versatile peptide-based materials, which is acting as another significant growth-inducing factor. Alongside this, the growing investment in the development of novel peptide therapeutics for autoimmune and inflammatory conditions is expected to create a favorable market outlook in the coming years.
Japan Peptide Therapeutics Market Segmentation:
Type Insights:
Type of Manufacturer Insights:
Synthesis Technology Insights:
- Solid Phase Peptide Synthesis
- Liquid Phase Peptide Synthesis
- Hybrid Technology
Routes of Administration Insights:
Application Insights:
- Gastrointestinal Disorders
- Neurological Disorders
- Metabolic Disorders
- Cancer
- Others
Competitive Landscape:
The market research report has also provided a comprehensive analysis of the competitive landscape. Competitive analysis such as market structure, key player positioning, top winning strategies, competitive dashboard, and company evaluation quadrant has been covered in the report. Also, detailed profiles of all major companies have been provided.
Key Questions Answered in This Report:
- How has the Japan peptide therapeutics market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the Japan peptide therapeutics market?
- What is the breakup of the Japan peptide therapeutics market on the basis of type?
- What is the breakup of the Japan peptide therapeutics market on the basis of type of manufacturer?
- What is the breakup of the Japan peptide therapeutics market on the basis of synthesis technology?
- What is the breakup of the Japan peptide therapeutics market on the basis of routes of administration?
- What is the breakup of the Japan peptide therapeutics market on the basis of application?
- What are the various stages in the value chain of the Japan peptide therapeutics market?
- What are the key driving factors and challenges in the Japan peptide therapeutics?
- What is the structure of the Japan peptide therapeutics market and who are the key players?
- What is the degree of competition in the Japan peptide therapeutics market?
Table of Contents
1 Preface
2 Scope and Methodology
- 2.1 Objectives of the Study
- 2.2 Stakeholders
- 2.3 Data Sources
- 2.3.1 Primary Sources
- 2.3.2 Secondary Sources
- 2.4 Market Estimation
- 2.4.1 Bottom-Up Approach
- 2.4.2 Top-Down Approach
- 2.5 Forecasting Methodology
3 Executive Summary
4 Japan Peptide Therapeutics Market - Introduction
- 4.1 Overview
- 4.2 Market Dynamics
- 4.3 Industry Trends
- 4.4 Competitive Intelligence
5 Japan Peptide Therapeutics Market Landscape
- 5.1 Historical and Current Market Trends (2019-2024)
- 5.2 Market Forecast (2025-2033)
6 Japan Peptide Therapeutics Market - Breakup by Type
- 6.1 Innovative
- 6.1.1 Overview
- 6.1.2 Historical and Current Market Trends (2019-2024)
- 6.1.3 Market Forecast (2025-2033)
- 6.2 Generic
- 6.2.1 Overview
- 6.2.2 Historical and Current Market Trends (2019-2024)
- 6.2.3 Market Forecast (2025-2033)
7 Japan Peptide Therapeutics Market - Breakup by Type of Manufacturer
- 7.1 Outsourced
- 7.1.1 Overview
- 7.1.2 Historical and Current Market Trends (2019-2024)
- 7.1.3 Market Forecast (2025-2033)
- 7.2 In-house
- 7.2.1 Overview
- 7.2.2 Historical and Current Market Trends (2019-2024)
- 7.2.3 Market Forecast (2025-2033)
8 Japan Peptide Therapeutics Market - Breakup by Synthesis Technology
- 8.1 Solid Phase Peptide Synthesis
- 8.1.1 Overview
- 8.1.2 Historical and Current Market Trends (2019-2024)
- 8.1.3 Market Forecast (2025-2033)
- 8.2 Liquid Phase Peptide Synthesis
- 8.2.1 Overview
- 8.2.2 Historical and Current Market Trends (2019-2024)
- 8.2.3 Market Forecast (2025-2033)
- 8.3 Hybrid Technology
- 8.3.1 Overview
- 8.3.2 Historical and Current Market Trends (2019-2024)
- 8.3.3 Market Forecast (2025-2033)
9 Japan Peptide Therapeutics Market - Breakup by Routes of Administration
- 9.1 Parenteral
- 9.1.1 Overview
- 9.1.2 Historical and Current Market Trends (2019-2024)
- 9.1.3 Market Forecast (2025-2033)
- 9.2 Oral
- 9.2.1 Overview
- 9.2.2 Historical and Current Market Trends (2019-2024)
- 9.2.3 Market Forecast (2025-2033)
- 9.3 Others
- 9.3.1 Historical and Current Market Trends (2019-2024)
- 9.3.2 Market Forecast (2025-2033)
10 Japan Peptide Therapeutics Market - Breakup by Application
- 10.1 Gastrointestinal Disorders
- 10.1.1 Overview
- 10.1.2 Historical and Current Market Trends (2019-2024)
- 10.1.3 Market Forecast (2025-2033)
- 10.2 Neurological Disorders
- 10.2.1 Overview
- 10.2.2 Historical and Current Market Trends (2019-2024)
- 10.2.3 Market Forecast (2025-2033)
- 10.3 Metabolic Disorders
- 10.3.1 Overview
- 10.3.2 Historical and Current Market Trends (2019-2024)
- 10.3.3 Market Forecast (2025-2033)
- 10.4 Cancer
- 10.4.1 Overview
- 10.4.2 Historical and Current Market Trends (2019-2024)
- 10.4.3 Market Forecast (2025-2033)
- 10.5 Others
- 10.5.1 Historical and Current Market Trends (2019-2024)
- 10.5.2 Market Forecast (2025-2033)
11 Japan Peptide Therapeutics Market - Competitive Landscape
- 11.1 Overview
- 11.2 Market Structure
- 11.3 Market Player Positioning
- 11.4 Top Winning Strategies
- 11.5 Competitive Dashboard
- 11.6 Company Evaluation Quadrant
12 Profiles of Key Players
- 12.1 Company A
- 12.1.1 Business Overview
- 12.1.2 Product Portfolio
- 12.1.3 Business Strategies
- 12.1.4 SWOT Analysis
- 12.1.5 Major News and Events
- 12.2 Company B
- 12.2.1 Business Overview
- 12.2.2 Product Portfolio
- 12.2.3 Business Strategies
- 12.2.4 SWOT Analysis
- 12.2.5 Major News and Events
- 12.3 Company C
- 12.3.1 Business Overview
- 12.3.2 Product Portfolio
- 12.3.3 Business Strategies
- 12.3.4 SWOT Analysis
- 12.3.5 Major News and Events
- 12.4 Company D
- 12.4.1 Business Overview
- 12.4.2 Product Portfolio
- 12.4.3 Business Strategies
- 12.4.4 SWOT Analysis
- 12.4.5 Major News and Events
- 12.5 Company E
- 12.5.1 Business Overview
- 12.5.2 Product Portfolio
- 12.5.3 Business Strategies
- 12.5.4 SWOT Analysis
- 12.5.5 Major News and Events
13 Japan Peptide Therapeutics Market - Industry Analysis
- 13.1 Drivers, Restraints, and Opportunities
- 13.1.1 Overview
- 13.1.2 Drivers
- 13.1.3 Restraints
- 13.1.4 Opportunities
- 13.2 Porters Five Forces Analysis
- 13.2.1 Overview
- 13.2.2 Bargaining Power of Buyers
- 13.2.3 Bargaining Power of Suppliers
- 13.2.4 Degree of Competition
- 13.2.5 Threat of New Entrants
- 13.2.6 Threat of Substitutes
- 13.3 Value Chain Analysis
14 Appendix
